The Former Director of the Center for Drug Evaluation and Research at FDA, Steven Galson, Joins Elephas as Independent Director

MADISON, Wis., July 28, 2022 /PRNewswire/ -- Elephas Biosciences Corporation (Elephas), a company developing novel cancer diagnostic solutions, announced today the appointment of Steven Galson, M.D., M.P.H., as a member of the Board of Directors. Dr. Galson is a consultant to Amgen and...

Click to view original post